In-Vitro And In-Vivo Assessment of Antigen-Encapsulated Dextran Nanoparticles


  • Prajapati R. School of pharmacy, SunRise University, Alwar, Rajasthan 301028
  • Babar V. B. School of pharmacy, SunRise University, Alwar, Rajasthan 301028



Dextran nanoparticles have become increasingly popular for drug delivery purposes. They are known for their improved stability, low toxicity, simple and gentle preparation process, and versatility in terms of administration methods. The small size of the particles is not only suitable for parenteral administration, but also appropriate for mucosal routes of administration like oral, nasal, and ocular mucosa. These routes are typically less intrusive. The dextran absorption enhancing effect also helps in making the application of mucosal delivery easier. In addition, dextran nanoparticles have shown great potential as an effective adjuvant in the field of vaccines. Therefore, the main objectives of this review are to offer a thorough summary of the different methods used to prepare dextran nanoparticles, explore the wide range of applications for these nanoparticles, and clarify how they are able to enter cells.


Download data is not yet available.


Metrics Loading ...


Nanoparticles, Stability, Vaccines, Antigen, Dextran, Mucosal.




How to Cite

R., P., & V. B., B. (2023). In-Vitro And In-Vivo Assessment of Antigen-Encapsulated Dextran Nanoparticles. International Journal of Newgen Research in Pharmacy & Healthcare, 1(2), 143–149.





Kumar, V. and G. S. Banker. Target-oriente drug delivery systems. In: Modern Pharmaceutics, by Banker, G. S. and C. T. Rhodes. New York, Marcel Dekker,1996. 611.

Parashar AK. Synthesis and characterization of temozolomide loaded theranostic quantum dots for the treatment of brain glioma. J Med Pharm Allied Sci [Internet]. 2021;10(3):2778– 82. Available from: DOI:

Topp MDC, Leunen IH, Dijkstra PJ, Tauer K, Schellenberg C, Feijen J. Macromolecules. 2000, 33: 4986-8. DOI:

Vila A, Sanchez M, Tobio P, Calvo MJ. Design of biodegradable particles for protein delivery. 2001, 15-24. DOI:

Parashar AK, Patel P, Kaurav M, Yadav K, Singh D, Gupta GD, et al. Nanomaterials as Diagnostic Tools and Drug Carriers. In: Nanoparticles and Nanocarriers-Based Pharmaceutical Formulations. Bentham Science Publishers; 2022. p. 126–56. DOI:

Vyas SP, Kohli DV. Methods in Biotechnology and Bioengineering. CBS Publishers & Distributors New Delhi. 2003. 146-151.

Wahdan MH, Serie Y, Cerisier S, Sallam R, Germanier C. A controlled field trial of live Salmonella typhi strain Ty21a oral vaccine against typhoid: three-year results. J Infect. 1982, 145: 292-296. DOI:

Wang TJ, Tsutsumi A, Hasegawa H, Mineo T. Mechanism of particle coating granulation with RESS process in a fluidized bedPowderTechnol. 2001. 118: 229. DOI:

World Health Organization Expert Committee on Biological Standardization. 1977; Technical Report Series, 610. WHO, Geneva Switzerland.

Balasubramanian SK, Yang L. Characterization, purification, and stability of nanoparticles. Biomaterials. 2010. 31(34), 9023–9030, DOI:

Yao C, Zhang L, Wang J. Dextran nanoparticle mediated phototherapy for cancer. Journal of Nanomaterials. 2016. 5497136. DOI:

Ren Y, Qi H, Chen Q, Ruan L. Thermal dosage investigation for optimal temperature distribution in gold nanoparticle enhanced photothermal therapy. Int J Heat Mass Transf. 2017;106:212–21. Available from: 2016.10.067 DOI:

Bankura KP, Maity D, Mollick MMR, Mondal D, Bhowmick B, Bain MK, et al. Synthesis, characterization and antimicrobial activity of dextran stabilized silver nanoparticles in aqueous medium. Carbohydr Polym [Internet]. 2012;89(4):1159–65. DOI:

Ferreccio C, Levine MM, Rodriguez H, Contreras R, Chilean Typhoid Committee. Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in Enteric-coated capsules: A field trial in an endemic area. J Infect Dis [Internet]. 1989;159(4):766–9. DOI:

McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine [Internet]. 1992;10(2):75–88. Available from: DOI: